{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:54:16Z","timestamp":1789044856331,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CM21\/00149"],"award-info":[{"award-number":["CM21\/00149"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Gerontology and Geriatrics"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.archger.2024.105365","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T12:24:10Z","timestamp":1707135850000},"page":"105365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Reducing the drug burden of sedative and anticholinergic medications in older adults: a scoping review of explicit decision criteria"],"prefix":"10.1016","volume":"121","author":[{"given":"Hector","family":"Rodr\u00edguez-Ramallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"B\u00e1ez-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"Villalba-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didiana","family":"Jaramillo Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Santos-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Prado-Mel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Sanchez-Fidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.archger.2024.105365_bib0001","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12877-019-1168-1","article-title":"Prevalence of potentially inappropriate medications use among older adults and risk factors using the 2015 American Geriatrics Society Beers criteria","volume":"19","author":"Alhawassi","year":"2019","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.archger.2024.105365_bib0002","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00228-019-02795-x","article-title":"Association between anticholinergic drug burden and mortality in older people: a systematic review","volume":"76","author":"Ali","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.archger.2024.105365_bib0003","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006544","article-title":"Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis","volume":"4","author":"Anderson","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.archger.2024.105365_bib0004","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1111\/j.1532-5415.2008.01916.x","article-title":"Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process","volume":"56","author":"Bain","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.archger.2024.105365_bib0005","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1007\/s11606-020-06089-2","article-title":"Deprescribing for Community-Dwelling Older Adults: a Systematic Review and Meta-analysis","volume":"35","author":"Bloomfield","year":"2020","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.archger.2024.105365_bib0006","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022500","article-title":"Anticholinergic and sedative drug burden in community-dwelling older people: a national database study","volume":"8","author":"Byrne","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.archger.2024.105365_bib0007","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/JCP.0b013e31818ce849","article-title":"Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people: a population-based study","volume":"28","author":"Cancelli","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.archger.2024.105365_bib0008","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/FAD.0b013e328323a63b","article-title":"Adverse reactions to drug withdrawal","author":"Coulson","year":"2008","journal-title":"Adverse Drug React Bull"},{"key":"10.1016\/j.archger.2024.105365_bib0009","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1532-5415.2011.03491.x","article-title":"Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study","volume":"59","author":"Fox","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.archger.2024.105365_bib0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/ejhpharm-2016-000959","article-title":"Overview of current and future research and clinical directions for drug discontinuation: psychological, traditional and professional obstacles to deprescribing","volume":"24","author":"Garfinkel","year":"2017","journal-title":"Eur J Hosp Pharm Sci Pract"},{"key":"10.1016\/j.archger.2024.105365_bib0011","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archinte.167.8.781","article-title":"A Drug Burden Index to Define the Functional Burden of Medications in Older People","volume":"167","author":"Hilmer","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.archger.2024.105365_bib0012","unstructured":"Home - Veterans\u2019 MATES [Internet]. [cited 2023 May 15]. Available from: https:\/\/www.veteransmates.net.au\/."},{"key":"10.1016\/j.archger.2024.105365_bib0013","first-page":"11","article-title":"Potential adverse effects of discontinuing psychotropic drugs. Part 1: Adrenergic, cholinergic, and histamine drugs","volume":"48","author":"Howland","year":"2010","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"10.1016\/j.archger.2024.105365_bib0014","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12877-021-02208-8","article-title":"A systematic review of the evidence for deprescribing interventions among older people living with frailty","volume":"21","author":"Ibrahim","year":"2021","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.archger.2024.105365_bib0015","unstructured":"Independent, reliable, respected - Therapeutic Guidelines."},{"key":"10.1016\/j.archger.2024.105365_bib0016","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/pds.2214","article-title":"Polypharmacy of potentially addictive medication in the older persons\u2013quantifying usage","volume":"21","author":"Ineke Neutel","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.archger.2024.105365_bib0017","doi-asserted-by":"crossref","DOI":"10.1177\/2150132719890227","article-title":"Appropriateness of Medications in Older Adults Living With Frailty: Impact of a Pharmacist-Led Structured Medication Review Process in Primary Care","volume":"10","author":"Khera","year":"2019","journal-title":"J Prim Care Community Health"},{"key":"10.1016\/j.archger.2024.105365_bib0018","first-page":"5","article-title":"The drug burden index: A new tool for HMRs?","volume":"32","author":"Kouladjian","year":"2013","journal-title":"Aust Pharm"},{"key":"10.1016\/j.archger.2024.105365_bib0019","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2165\/11536650-000000000-00000","article-title":"Effects of medication assessment as part of a comprehensive geriatric assessment on drug use over a 1-year period: a population-based intervention study","volume":"27","author":"Lampela","year":"2010","journal-title":"Drugs Aging"},{"key":"10.1016\/j.archger.2024.105365_bib0020","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1056\/NEJM200305013481819","article-title":"Preventing falls in elderly persons","volume":"348","author":"Leslie","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.archger.2024.105365_bib0021","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/gerona\/glaa060","article-title":"Chronic Polypharmacy with Increasing Drug Burden Index Exacerbates Frailty and Impairs Physical Function, with Effects Attenuated by Deprescribing, in Aged Mice","volume":"76","author":"Mach","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.archger.2024.105365_bib0022","doi-asserted-by":"crossref","first-page":"862.e1","DOI":"10.1016\/j.jamda.2016.06.011","article-title":"Prevalence of Potentially Inappropriate Medication Use in Older Adults Living in Nursing Homes: A Systematic Review","volume":"17","author":"Morin","year":"2016","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.archger.2024.105365_bib0023","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00228-018-2446-0","article-title":"Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria","volume":"74","author":"Motter","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.archger.2024.105365_bib0024","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1111\/jgs.13647","article-title":"Concordance Between Anticholinergic Burden Scales","volume":"63","author":"Naples","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.archger.2024.105365_bib0025","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1177\/0091270009345690","article-title":"Anticholinergic activity of commonly prescribed medications and neuropsychiatric adverse events in older people","volume":"49","author":"Nishtala","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.archger.2024.105365_bib0026","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 3","author":"O'Mahony","year":"2023","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.archger.2024.105365_bib0027","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/bcp.12975","article-title":"The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis","volume":"82","author":"Page","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.archger.2024.105365_bib0028","unstructured":"Peters M. Apply PCC. University of South Australia. [Internet]. [cited 2023 may 20]. Available from: https:\/\/guides.library.unisa.edu.au\/ScopingReviews\/Home."},{"key":"10.1016\/j.archger.2024.105365_bib0029","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/XEB.0000000000000277","article-title":"Updated methodological guidance for the conduct of scoping reviews","volume":"19","author":"Peters","year":"2021","journal-title":"JBI Evid Implement"},{"key":"10.1016\/j.archger.2024.105365_bib0030","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/ageing\/afaa090","article-title":"Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis","volume":"49","author":"Pieper","year":"2020","journal-title":"Age Ageing"},{"issue":"3","key":"10.1016\/j.archger.2024.105365_bib0031","doi-asserted-by":"crossref","first-page":"520","DOI":"10.11124\/JBIES-22-00123","article-title":"Recommendations for the extraction, analysis, and presentation of results in scoping reviews","volume":"21","author":"Pollock","year":"2023","journal-title":"JBI Evid Synth"},{"key":"10.1016\/j.archger.2024.105365_bib0032","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s40360-022-00637-8","article-title":"Association between anticholinergic activity and xerostomia and\/or xerophthalmia in the elderly: systematic review","volume":"23","author":"Prado-Mel","year":"2022","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.archger.2024.105365_bib0033","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3233\/JAD-170842","article-title":"Prevalence of Potentially Inappropriate Medication Use in Older Inpatients with and without Cognitive Impairment: A Systematic Review","volume":"61","author":"Redston","year":"2018","journal-title":"J Alzheimers Dis JAD"},{"key":"10.1016\/j.archger.2024.105365_bib0034","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/bcp.12732","article-title":"A systematic review of the emerging definition of \u201cdeprescribing\u201d with network analysis: implications for future research and clinical practice","volume":"80","author":"Reeve","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.archger.2024.105365_bib0035","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/ggi.13062","article-title":"Novel tool for deprescribing in chronic patients with multimorbidity: List of Evidence-Based Deprescribing for Chronic Patients criteria","volume":"17","author":"Rodr\u00edguez-P\u00e9rez","year":"2017","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.archger.2024.105365_bib0036","first-page":"581","article-title":"Association between Anticholinergic Burden and Constipation: A Systematic Review","volume":"9","author":"Rodr\u00edguez-Ramallo","year":"2021","journal-title":"Healthc Basel Switz"},{"key":"10.1016\/j.archger.2024.105365_bib0037","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","article-title":"The anticholinergic risk scale and anticholinergic adverse effects in older persons","volume":"168","author":"Rudolph","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.archger.2024.105365_bib0038","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/bcp.12617","article-title":"Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis","volume":"80","author":"Ruxton","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.archger.2024.105365_bib0039","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12877-015-0029-9","article-title":"Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review","volume":"15","author":"Salahudeen","year":"2015","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.archger.2024.105365_bib0040","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/17512433.2020.1730812","article-title":"A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review","volume":"13","author":"Sawan","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.archger.2024.105365_bib0041","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s11096-021-01293-4","article-title":"Barriers and facilitators to reducing anticholinergic burden: a qualitative systematic review","volume":"43","author":"Stewart","year":"2021","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.archger.2024.105365_bib0042","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"issue":"21","key":"10.1016\/j.archger.2024.105365_bib0043","first-page":"11","article-title":"Anticholinergic effects of medication in elderly patients","volume":"62","author":"Tune","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.archger.2024.105365_bib0044","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1001\/archinte.166.15.1666","article-title":"Represcription after adverse drug reaction in the elderly: a descriptive study","volume":"166","author":"van der Linden","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.archger.2024.105365_bib0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001461","article-title":"How are drug regimen changes during hospitalisation handled after discharge: a cohort study","volume":"2","author":"Viktil","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.archger.2024.105365_bib0046","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.2174\/1381612824666180327154239","article-title":"Association Between Drug Burden Index and Functional and Cognitive Function in Patients with Multimorbidity","volume":"24","author":"Villalba-Moreno","year":"2018","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.archger.2024.105365_bib0047","article-title":"Implementation considerations of deprescribing interventions: A scoping review","author":"Wang","year":"2022","journal-title":"J Intern Med"},{"key":"10.1016\/j.archger.2024.105365_bib0048","doi-asserted-by":"crossref","first-page":"E87","DOI":"10.9778\/cmajo.20170134","article-title":"A pilot study of a Medication Rationalization (MERA) intervention","volume":"6","author":"Whitty","year":"2018","journal-title":"CMAJ Open"},{"key":"10.1016\/j.archger.2024.105365_bib0049","first-page":"1","article-title":"Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)\u2013a pharmacoepidemiological and qualitative study","volume":"13","author":"Wong","year":"2009","journal-title":"Health Technol Assess Winch Engl"},{"key":"10.1016\/j.archger.2024.105365_bib0050","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/ageing\/afz109","article-title":"New horizons in deprescribing for older people","volume":"48","author":"Woodford","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.archger.2024.105365_bib0051","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jppr2003334323","article-title":"Deprescribing: Achieving Better Health Outcomes for Older People through Reducing Medications","volume":"33","author":"Woodward","year":"2003","journal-title":"J Pharm Pract Res"}],"container-title":["Archives of Gerontology and Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167494324000414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167494324000414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:15:40Z","timestamp":1759090540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167494324000414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":51,"alternative-id":["S0167494324000414"],"URL":"https:\/\/doi.org\/10.1016\/j.archger.2024.105365","relation":{},"ISSN":["0167-4943"],"issn-type":[{"value":"0167-4943","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reducing the drug burden of sedative and anticholinergic medications in older adults: a scoping review of explicit decision criteria","name":"articletitle","label":"Article Title"},{"value":"Archives of Gerontology and Geriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.archger.2024.105365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105365"}}